A recurring theme of the third-quarter trading updates filtering through the market has been e-commerce darlings turning into one-trick ponies, having failed to meet the street’s lofty expectations.
But Sage Capital portfolio manager Kelli Meagher takes a more nuanced approach to assessing the ASX’s supposed winners and losers from the coronavirus. A winning trade during COVID-19 has been Fisher & Paykel Healthcare, which it began buying as soon as virus numbers in China started to go up at the start of last year.
Loading...
Vesna Poljak is the Companies editor. She was previously the Markets editor with a special interest in the investment industry, hedge funds and accounting. She is based in the Sydney newsroom. Connect with Vesna on Twitter. Email Vesna at vpoljak@afr.com
